Overview

An Open Label Trial of Bupropion and Naltrexone for Binge Drinking

Status:
Completed
Trial end date:
2017-12-13
Target enrollment:
Participant gender:
Summary
This is an open-label Phase IIa pilot study of the tolerability and effects on binge drinking of bupropion and naltrexone for binge drinkers.
Phase:
Phase 2
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
North Carolina Translational and Clinical Sciences Institute
Treatments:
Bupropion
Naltrexone